FIGS stock soars 66% following InvestingPro’s April Fair Value signal

Published 22/07/2025, 12:06
FIGS stock soars 66% following InvestingPro’s April Fair Value signal

In a compelling validation of InvestingPro’s Fair Value analysis capabilities, healthcare apparel maker FIGS, Inc. (NYSE:FIGS) has delivered an impressive 66% return since being identified as significantly undervalued in early April 2025. This success story demonstrates how sophisticated valuation models can help investors identify meaningful market opportunities. For investors seeking similar opportunities, InvestingPro’s Most undervalued list continues to highlight promising stocks with potential upside.

FIGS, a direct-to-consumer healthcare apparel company known for its premium scrubs and medical wear, caught the attention of InvestingPro’s Fair Value models when trading at $3.62 on April 8, 2025. At that time, the company showed strong fundamentals with $561 million in revenue and healthy gross margins of 67.35%, despite experiencing volatile trading in the preceding months.

The Fair Value analysis identified a significant mispricing, estimating an upside potential of approximately 50%. This assessment was based on FIGS’ strong brand recognition in healthcare apparel, robust financial position, and strategic growth initiatives, including international expansion plans and operational improvements through a new distribution center.

The stock’s subsequent performance has thoroughly validated this analysis. From the April signal price of $3.62, FIGS shares climbed steadily to reach $6.03 by mid-July 2025, delivering a total return of 66% in just over three months. This movement was supported by several positive developments, including stronger-than-expected Q1 2025 earnings and the unveiling of strategic expansion plans at the Consumer Growth Conference.

Recent analyst coverage reflects the company’s improved market position, with Barclays (LON:BARC) Capital raising its price target from $4.00 to $5.00 in May 2025. The company’s fundamentals remain strong, supported by its premium brand positioning and expansion initiatives in the growing healthcare apparel market.

InvestingPro’s Fair Value methodology combines multiple valuation approaches, including discounted cash flow analysis, comparable company metrics, and market-based factors, to provide a comprehensive assessment of a stock’s intrinsic value. This multi-faceted approach helps investors identify opportunities where market prices significantly deviate from fundamental value.

For investors looking to uncover similar opportunities, InvestingPro offers access to these sophisticated valuation tools, along with real-time alerts, detailed financial analysis, and professional-grade research capabilities. Learn more about InvestingPro to gain access to actionable insights that can help identify tomorrow’s market opportunities today.

Latest comments

Ever wondered how to spot an undervalued gem?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.